1-Methyltryptophan

Chemical compound From Wikipedia, the free encyclopedia

1-Methyltryptophan is a chemical compound that is an inhibitor of the tryptophan catabolic enzyme indoleamine 2,3-dioxygenase (IDO or INDO EC 1.13.11.52).[1] It is a chiral compound that can exist as both D- and L-enantiomers.

Quick facts Names, Identifiers ...
1-Methyltryptophan
Names
IUPAC name
1-Methyltryptophan
Systematic IUPAC name
2-Amino-3-(1-methyl-1H-indol-3-yl)propanoic acid
Other names
1-Methyl-DL-tryptophan; DL-1-Methyltryptophan; ARBRIN; Indoximod
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard 100.043.765 Edit this at Wikidata
  • InChI=1S/C12H14N2O2/c1-14-7-8(6-10(13)12(15)16)9-4-2-3-5-11(9)14/h2-5,7,10H,6,13H2,1H3,(H,15,16) checkY
    Key: ZADWXFSZEAPBJS-UHFFFAOYSA-N checkY
  • InChI=1S/C12H14N2O2/c1-14-7-8(6-10(13)12(15)16)9-4-2-3-5-11(9)14/h2-5,7,10H,6,13H2,1H3,(H,15,16)
    Key: ZADWXFSZEAPBJS-UHFFFAOYSA-N
  • O=C(O)C(N)Cc2c1ccccc1n(c2)C
Properties
C12H14N2O2
Molar mass 218.256 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Close

The L-isomer (L-1MT) inhibits IDO weakly but also serves as an enzyme substrate.

The D-isomer (D-1MT) does not inhibit IDO at all, but it can inhibit the IDO-related enzyme IDO2[2] and restore mTOR signaling in cells starved of tryptophan due to IDO activity.[3] D-1MT is also known as indoximod and it was in clinical trials for cancer treatment, such as for advanced melanoma, in 2017.[4][needs update]

A U.S. patent covering salt and prodrug formulations of indoximod was issued to NewLink Genetics on August 15, 2017, providing exclusivity until at least 2036.[5][6]

References

Related Articles

Wikiwand AI